Review



primary antibody [nr2a, p‐nr2a (tyr1246), nr2b, p‐nr2b (tyr1472), p‐erk and p‐creb  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Cell Signaling Technology Inc primary antibody [nr2a, p‐nr2a (tyr1246), nr2b, p‐nr2b (tyr1472), p‐erk and p‐creb
    Images and plots of western blotting analysis of D1R/ERK/CREB signalling pathway in the NAc after the pretreatment of D‐AP5 in bilateral NAsh in propofol self‐administrated rats. The expressions of D1R (A, p < 0.001, n = 7, ANOVA), p‐ERK1/2 (B, p = 0.001, n = 7, Kruskal–Wallis) and <t>p‐CREB</t> (D, p = 0.001, n = 7, ANOVA) in the NAc were statistically significantly increased in a dose‐dependent manner by D‐AP5 pretreatment. Compared with the vehicle group, the pairwise analysis showed the difference reached a statistical significance at the dose of 2.0–4.0 μg/0.3 μL/site for D1Rs (2.0 group p < 0.001, 4.0 group p < 0.001, Dunnett) and p‐CREB (p‐CREB, 2.0 group p = 0.003, 4.0 group p = 0.001, Dunnett), and at the dose of 4.0 μg/0.3 μL/site for p‐ERK1/2 ( p = 0.001, Dunn). D‐AP5 pretreatment failed to affect the expression of t‐ERK1/2 (C, p = 0.996, n = 6, ANOVA) and t‐CREB (E, p = 0.798, n = 6, ANOVA) in the NAc. p‐ERK1/2 = phosphorylated ERK1/2, t‐ERK1/2 = total ERK1/2, p‐CREB = phosphorylated <t>CREB,</t> <t>t‐NR2B</t> = total CREB. The normally distributed data were analysed with one‐way ANOVA, and Dunnett's post hoc test was conducted for multiple comparisons; otherwise, the data that did not meet the criteria of normal distribution were analysed by Kruskal–Wallis test with Dunn's post hoc analysis for multiple comparisons. Compared with the vehicle group, ** p < 0.01, *** p < 0.001.
    Primary Antibody [Nr2a, P‐Nr2a (Tyr1246), Nr2b, P‐Nr2b (Tyr1472), P‐Erk And P‐Creb, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nr2a+primary+antibodies/anti+nr2a/pmc11116088-77-43-46
    Average 90 stars, based on 1 article reviews
    primary antibody [nr2a, p‐nr2a (tyr1246), nr2b, p‐nr2b (tyr1472), p‐erk and p‐creb - by Bioz Stars, 2026-09
    90/100 stars

    Images

    1) Product Images from "NMDA receptor within nucleus accumbens shell regulates propofol self‐administration through D1R/ERK/CREB signalling pathway"

    Article Title: NMDA receptor within nucleus accumbens shell regulates propofol self‐administration through D1R/ERK/CREB signalling pathway

    Journal: Addiction Biology

    doi: 10.1111/adb.13401

    Images and plots of western blotting analysis of D1R/ERK/CREB signalling pathway in the NAc after the pretreatment of D‐AP5 in bilateral NAsh in propofol self‐administrated rats. The expressions of D1R (A, p < 0.001, n = 7, ANOVA), p‐ERK1/2 (B, p = 0.001, n = 7, Kruskal–Wallis) and p‐CREB (D, p = 0.001, n = 7, ANOVA) in the NAc were statistically significantly increased in a dose‐dependent manner by D‐AP5 pretreatment. Compared with the vehicle group, the pairwise analysis showed the difference reached a statistical significance at the dose of 2.0–4.0 μg/0.3 μL/site for D1Rs (2.0 group p < 0.001, 4.0 group p < 0.001, Dunnett) and p‐CREB (p‐CREB, 2.0 group p = 0.003, 4.0 group p = 0.001, Dunnett), and at the dose of 4.0 μg/0.3 μL/site for p‐ERK1/2 ( p = 0.001, Dunn). D‐AP5 pretreatment failed to affect the expression of t‐ERK1/2 (C, p = 0.996, n = 6, ANOVA) and t‐CREB (E, p = 0.798, n = 6, ANOVA) in the NAc. p‐ERK1/2 = phosphorylated ERK1/2, t‐ERK1/2 = total ERK1/2, p‐CREB = phosphorylated CREB, t‐NR2B = total CREB. The normally distributed data were analysed with one‐way ANOVA, and Dunnett's post hoc test was conducted for multiple comparisons; otherwise, the data that did not meet the criteria of normal distribution were analysed by Kruskal–Wallis test with Dunn's post hoc analysis for multiple comparisons. Compared with the vehicle group, ** p < 0.01, *** p < 0.001.
    Figure Legend Snippet: Images and plots of western blotting analysis of D1R/ERK/CREB signalling pathway in the NAc after the pretreatment of D‐AP5 in bilateral NAsh in propofol self‐administrated rats. The expressions of D1R (A, p < 0.001, n = 7, ANOVA), p‐ERK1/2 (B, p = 0.001, n = 7, Kruskal–Wallis) and p‐CREB (D, p = 0.001, n = 7, ANOVA) in the NAc were statistically significantly increased in a dose‐dependent manner by D‐AP5 pretreatment. Compared with the vehicle group, the pairwise analysis showed the difference reached a statistical significance at the dose of 2.0–4.0 μg/0.3 μL/site for D1Rs (2.0 group p < 0.001, 4.0 group p < 0.001, Dunnett) and p‐CREB (p‐CREB, 2.0 group p = 0.003, 4.0 group p = 0.001, Dunnett), and at the dose of 4.0 μg/0.3 μL/site for p‐ERK1/2 ( p = 0.001, Dunn). D‐AP5 pretreatment failed to affect the expression of t‐ERK1/2 (C, p = 0.996, n = 6, ANOVA) and t‐CREB (E, p = 0.798, n = 6, ANOVA) in the NAc. p‐ERK1/2 = phosphorylated ERK1/2, t‐ERK1/2 = total ERK1/2, p‐CREB = phosphorylated CREB, t‐NR2B = total CREB. The normally distributed data were analysed with one‐way ANOVA, and Dunnett's post hoc test was conducted for multiple comparisons; otherwise, the data that did not meet the criteria of normal distribution were analysed by Kruskal–Wallis test with Dunn's post hoc analysis for multiple comparisons. Compared with the vehicle group, ** p < 0.01, *** p < 0.001.

    Techniques Used: Western Blot, Expressing

    Related Articles

    Blocking Assay:

    Article Title: Repeated cocaine enhances ventral hippocampal-stimulated dopamine efflux in the nucleus accumbens and alters ventral hippocampal NMDA receptor subunit expression
    Article Snippet: Equal amounts of protein (40 μg, determined using a Thermo Scientific NanoDrop 2000 spectrometer) from all samples were loaded on 7.5% mini-Protean TGX gels (Bio Rad) for separation and transferred onto nitrocellulose membranes. .. After blocking for 60 minutes at room temperature, the membranes were incubated overnight at 4 °C with rabbit anti-NR1, NR2B or NR2A primary antibodies (1:1000; mAb #5704; #4205; #4212; Cell Signaling, Danvers, MA). .. After washing, the membranes were further incubated with IRDye 800 or 680-conjugated goat anti-rabbit IgG second antibody (Li-Cor Biosciences, Lincoln, NE 1:10,000) for 2 hr at room temperature.

    Incubation:

    Article Title: Repeated cocaine enhances ventral hippocampal-stimulated dopamine efflux in the nucleus accumbens and alters ventral hippocampal NMDA receptor subunit expression
    Article Snippet: Equal amounts of protein (40 μg, determined using a Thermo Scientific NanoDrop 2000 spectrometer) from all samples were loaded on 7.5% mini-Protean TGX gels (Bio Rad) for separation and transferred onto nitrocellulose membranes. .. After blocking for 60 minutes at room temperature, the membranes were incubated overnight at 4 °C with rabbit anti-NR1, NR2B or NR2A primary antibodies (1:1000; mAb #5704; #4205; #4212; Cell Signaling, Danvers, MA). .. After washing, the membranes were further incubated with IRDye 800 or 680-conjugated goat anti-rabbit IgG second antibody (Li-Cor Biosciences, Lincoln, NE 1:10,000) for 2 hr at room temperature.



    Similar Products

    90
    Cell Signaling Technology Inc primary antibody [nr2a, p‐nr2a (tyr1246), nr2b, p‐nr2b (tyr1472), p‐erk and p‐creb
    Images and plots of western blotting analysis of D1R/ERK/CREB signalling pathway in the NAc after the pretreatment of D‐AP5 in bilateral NAsh in propofol self‐administrated rats. The expressions of D1R (A, p < 0.001, n = 7, ANOVA), p‐ERK1/2 (B, p = 0.001, n = 7, Kruskal–Wallis) and <t>p‐CREB</t> (D, p = 0.001, n = 7, ANOVA) in the NAc were statistically significantly increased in a dose‐dependent manner by D‐AP5 pretreatment. Compared with the vehicle group, the pairwise analysis showed the difference reached a statistical significance at the dose of 2.0–4.0 μg/0.3 μL/site for D1Rs (2.0 group p < 0.001, 4.0 group p < 0.001, Dunnett) and p‐CREB (p‐CREB, 2.0 group p = 0.003, 4.0 group p = 0.001, Dunnett), and at the dose of 4.0 μg/0.3 μL/site for p‐ERK1/2 ( p = 0.001, Dunn). D‐AP5 pretreatment failed to affect the expression of t‐ERK1/2 (C, p = 0.996, n = 6, ANOVA) and t‐CREB (E, p = 0.798, n = 6, ANOVA) in the NAc. p‐ERK1/2 = phosphorylated ERK1/2, t‐ERK1/2 = total ERK1/2, p‐CREB = phosphorylated <t>CREB,</t> <t>t‐NR2B</t> = total CREB. The normally distributed data were analysed with one‐way ANOVA, and Dunnett's post hoc test was conducted for multiple comparisons; otherwise, the data that did not meet the criteria of normal distribution were analysed by Kruskal–Wallis test with Dunn's post hoc analysis for multiple comparisons. Compared with the vehicle group, ** p < 0.01, *** p < 0.001.
    Primary Antibody [Nr2a, P‐Nr2a (Tyr1246), Nr2b, P‐Nr2b (Tyr1472), P‐Erk And P‐Creb, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nr2a+primary+antibodies/anti+nr2a/pmc11116088-77-43-46
    Average 90 stars, based on 1 article reviews
    primary antibody [nr2a, p‐nr2a (tyr1246), nr2b, p‐nr2b (tyr1472), p‐erk and p‐creb - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc primary antibody [nr2a, p-nr2a (tyr1246), nr2b, p-nr2b (tyr1472), p-erk and p-creb, rabbit, 1:1000]
    Images and plots of western blotting analysis of D1R/ERK/CREB signalling pathway in the NAc after the pretreatment of D‐AP5 in bilateral NAsh in propofol self‐administrated rats. The expressions of D1R (A, p < 0.001, n = 7, ANOVA), p‐ERK1/2 (B, p = 0.001, n = 7, Kruskal–Wallis) and <t>p‐CREB</t> (D, p = 0.001, n = 7, ANOVA) in the NAc were statistically significantly increased in a dose‐dependent manner by D‐AP5 pretreatment. Compared with the vehicle group, the pairwise analysis showed the difference reached a statistical significance at the dose of 2.0–4.0 μg/0.3 μL/site for D1Rs (2.0 group p < 0.001, 4.0 group p < 0.001, Dunnett) and p‐CREB (p‐CREB, 2.0 group p = 0.003, 4.0 group p = 0.001, Dunnett), and at the dose of 4.0 μg/0.3 μL/site for p‐ERK1/2 ( p = 0.001, Dunn). D‐AP5 pretreatment failed to affect the expression of t‐ERK1/2 (C, p = 0.996, n = 6, ANOVA) and t‐CREB (E, p = 0.798, n = 6, ANOVA) in the NAc. p‐ERK1/2 = phosphorylated ERK1/2, t‐ERK1/2 = total ERK1/2, p‐CREB = phosphorylated <t>CREB,</t> <t>t‐NR2B</t> = total CREB. The normally distributed data were analysed with one‐way ANOVA, and Dunnett's post hoc test was conducted for multiple comparisons; otherwise, the data that did not meet the criteria of normal distribution were analysed by Kruskal–Wallis test with Dunn's post hoc analysis for multiple comparisons. Compared with the vehicle group, ** p < 0.01, *** p < 0.001.
    Primary Antibody [Nr2a, P Nr2a (Tyr1246), Nr2b, P Nr2b (Tyr1472), P Erk And P Creb, Rabbit, 1:1000], supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nr2a+primary+antibodies/anti+nr2a/pmc11116088-77-44-46
    Average 90 stars, based on 1 article reviews
    primary antibody [nr2a, p-nr2a (tyr1246), nr2b, p-nr2b (tyr1472), p-erk and p-creb, rabbit, 1:1000] - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Merck KGaA primary antibody for nr2a
    Images and plots of western blotting analysis of D1R/ERK/CREB signalling pathway in the NAc after the pretreatment of D‐AP5 in bilateral NAsh in propofol self‐administrated rats. The expressions of D1R (A, p < 0.001, n = 7, ANOVA), p‐ERK1/2 (B, p = 0.001, n = 7, Kruskal–Wallis) and <t>p‐CREB</t> (D, p = 0.001, n = 7, ANOVA) in the NAc were statistically significantly increased in a dose‐dependent manner by D‐AP5 pretreatment. Compared with the vehicle group, the pairwise analysis showed the difference reached a statistical significance at the dose of 2.0–4.0 μg/0.3 μL/site for D1Rs (2.0 group p < 0.001, 4.0 group p < 0.001, Dunnett) and p‐CREB (p‐CREB, 2.0 group p = 0.003, 4.0 group p = 0.001, Dunnett), and at the dose of 4.0 μg/0.3 μL/site for p‐ERK1/2 ( p = 0.001, Dunn). D‐AP5 pretreatment failed to affect the expression of t‐ERK1/2 (C, p = 0.996, n = 6, ANOVA) and t‐CREB (E, p = 0.798, n = 6, ANOVA) in the NAc. p‐ERK1/2 = phosphorylated ERK1/2, t‐ERK1/2 = total ERK1/2, p‐CREB = phosphorylated <t>CREB,</t> <t>t‐NR2B</t> = total CREB. The normally distributed data were analysed with one‐way ANOVA, and Dunnett's post hoc test was conducted for multiple comparisons; otherwise, the data that did not meet the criteria of normal distribution were analysed by Kruskal–Wallis test with Dunn's post hoc analysis for multiple comparisons. Compared with the vehicle group, ** p < 0.01, *** p < 0.001.
    Primary Antibody For Nr2a, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nr2a+primary+antibodies/anti+nr2a/pm38471625-134-15-45
    Average 90 stars, based on 1 article reviews
    primary antibody for nr2a - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc primary antibodies against nr1, phospho-s896-nr1, nr2a, nr2b
    Images and plots of western blotting analysis of D1R/ERK/CREB signalling pathway in the NAc after the pretreatment of D‐AP5 in bilateral NAsh in propofol self‐administrated rats. The expressions of D1R (A, p < 0.001, n = 7, ANOVA), p‐ERK1/2 (B, p = 0.001, n = 7, Kruskal–Wallis) and <t>p‐CREB</t> (D, p = 0.001, n = 7, ANOVA) in the NAc were statistically significantly increased in a dose‐dependent manner by D‐AP5 pretreatment. Compared with the vehicle group, the pairwise analysis showed the difference reached a statistical significance at the dose of 2.0–4.0 μg/0.3 μL/site for D1Rs (2.0 group p < 0.001, 4.0 group p < 0.001, Dunnett) and p‐CREB (p‐CREB, 2.0 group p = 0.003, 4.0 group p = 0.001, Dunnett), and at the dose of 4.0 μg/0.3 μL/site for p‐ERK1/2 ( p = 0.001, Dunn). D‐AP5 pretreatment failed to affect the expression of t‐ERK1/2 (C, p = 0.996, n = 6, ANOVA) and t‐CREB (E, p = 0.798, n = 6, ANOVA) in the NAc. p‐ERK1/2 = phosphorylated ERK1/2, t‐ERK1/2 = total ERK1/2, p‐CREB = phosphorylated <t>CREB,</t> <t>t‐NR2B</t> = total CREB. The normally distributed data were analysed with one‐way ANOVA, and Dunnett's post hoc test was conducted for multiple comparisons; otherwise, the data that did not meet the criteria of normal distribution were analysed by Kruskal–Wallis test with Dunn's post hoc analysis for multiple comparisons. Compared with the vehicle group, ** p < 0.01, *** p < 0.001.
    Primary Antibodies Against Nr1, Phospho S896 Nr1, Nr2a, Nr2b, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nr2a+primary+antibodies/anti+nr2a/pm38253241-65-6-7
    Average 90 stars, based on 1 article reviews
    primary antibodies against nr1, phospho-s896-nr1, nr2a, nr2b - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    ZenBio primary antibodies against creb, pcreb, nr2a, nr2b, bdnf, mtor, p-mtor
    Images and plots of western blotting analysis of D1R/ERK/CREB signalling pathway in the NAc after the pretreatment of D‐AP5 in bilateral NAsh in propofol self‐administrated rats. The expressions of D1R (A, p < 0.001, n = 7, ANOVA), p‐ERK1/2 (B, p = 0.001, n = 7, Kruskal–Wallis) and <t>p‐CREB</t> (D, p = 0.001, n = 7, ANOVA) in the NAc were statistically significantly increased in a dose‐dependent manner by D‐AP5 pretreatment. Compared with the vehicle group, the pairwise analysis showed the difference reached a statistical significance at the dose of 2.0–4.0 μg/0.3 μL/site for D1Rs (2.0 group p < 0.001, 4.0 group p < 0.001, Dunnett) and p‐CREB (p‐CREB, 2.0 group p = 0.003, 4.0 group p = 0.001, Dunnett), and at the dose of 4.0 μg/0.3 μL/site for p‐ERK1/2 ( p = 0.001, Dunn). D‐AP5 pretreatment failed to affect the expression of t‐ERK1/2 (C, p = 0.996, n = 6, ANOVA) and t‐CREB (E, p = 0.798, n = 6, ANOVA) in the NAc. p‐ERK1/2 = phosphorylated ERK1/2, t‐ERK1/2 = total ERK1/2, p‐CREB = phosphorylated <t>CREB,</t> <t>t‐NR2B</t> = total CREB. The normally distributed data were analysed with one‐way ANOVA, and Dunnett's post hoc test was conducted for multiple comparisons; otherwise, the data that did not meet the criteria of normal distribution were analysed by Kruskal–Wallis test with Dunn's post hoc analysis for multiple comparisons. Compared with the vehicle group, ** p < 0.01, *** p < 0.001.
    Primary Antibodies Against Creb, Pcreb, Nr2a, Nr2b, Bdnf, Mtor, P Mtor, supplied by ZenBio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nr2a+primary+antibodies/primary+antibodies+against+creb++pcreb++nr2a++nr2b++bdnf++mtor++p+mtor/pm38216855-65-11-20
    Average 90 stars, based on 1 article reviews
    primary antibodies against creb, pcreb, nr2a, nr2b, bdnf, mtor, p-mtor - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    GeneTex primary antibodies against nr2a
    Images and plots of western blotting analysis of D1R/ERK/CREB signalling pathway in the NAc after the pretreatment of D‐AP5 in bilateral NAsh in propofol self‐administrated rats. The expressions of D1R (A, p < 0.001, n = 7, ANOVA), p‐ERK1/2 (B, p = 0.001, n = 7, Kruskal–Wallis) and <t>p‐CREB</t> (D, p = 0.001, n = 7, ANOVA) in the NAc were statistically significantly increased in a dose‐dependent manner by D‐AP5 pretreatment. Compared with the vehicle group, the pairwise analysis showed the difference reached a statistical significance at the dose of 2.0–4.0 μg/0.3 μL/site for D1Rs (2.0 group p < 0.001, 4.0 group p < 0.001, Dunnett) and p‐CREB (p‐CREB, 2.0 group p = 0.003, 4.0 group p = 0.001, Dunnett), and at the dose of 4.0 μg/0.3 μL/site for p‐ERK1/2 ( p = 0.001, Dunn). D‐AP5 pretreatment failed to affect the expression of t‐ERK1/2 (C, p = 0.996, n = 6, ANOVA) and t‐CREB (E, p = 0.798, n = 6, ANOVA) in the NAc. p‐ERK1/2 = phosphorylated ERK1/2, t‐ERK1/2 = total ERK1/2, p‐CREB = phosphorylated <t>CREB,</t> <t>t‐NR2B</t> = total CREB. The normally distributed data were analysed with one‐way ANOVA, and Dunnett's post hoc test was conducted for multiple comparisons; otherwise, the data that did not meet the criteria of normal distribution were analysed by Kruskal–Wallis test with Dunn's post hoc analysis for multiple comparisons. Compared with the vehicle group, ** p < 0.01, *** p < 0.001.
    Primary Antibodies Against Nr2a, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nr2a+primary+antibodies/n+methyl+d+aspartate++nmda++receptor+2a++nr2a+antibody/pm36739954-80-29-35
    Average 90 stars, based on 1 article reviews
    primary antibodies against nr2a - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    93
    Proteintech nr2a primary antibody
    Primers used for RT-PCR analysis
    Nr2a Primary Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nr2a+primary+antibodies/NMDAR2A%2FGRIN2A+Antibody/pmc08200643-43-0-14
    Average 93 stars, based on 1 article reviews
    nr2a primary antibody - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    90
    Millipore primary antibody against nr2a ab1555p
    <t>VGlut2</t> expression in the left and right visual cortex
    Primary Antibody Against Nr2a Ab1555p, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nr2a+primary+antibodies/nr2b+antibody/pmc06021019-99-10-15
    Average 90 stars, based on 1 article reviews
    primary antibody against nr2a ab1555p - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    Images and plots of western blotting analysis of D1R/ERK/CREB signalling pathway in the NAc after the pretreatment of D‐AP5 in bilateral NAsh in propofol self‐administrated rats. The expressions of D1R (A, p < 0.001, n = 7, ANOVA), p‐ERK1/2 (B, p = 0.001, n = 7, Kruskal–Wallis) and p‐CREB (D, p = 0.001, n = 7, ANOVA) in the NAc were statistically significantly increased in a dose‐dependent manner by D‐AP5 pretreatment. Compared with the vehicle group, the pairwise analysis showed the difference reached a statistical significance at the dose of 2.0–4.0 μg/0.3 μL/site for D1Rs (2.0 group p < 0.001, 4.0 group p < 0.001, Dunnett) and p‐CREB (p‐CREB, 2.0 group p = 0.003, 4.0 group p = 0.001, Dunnett), and at the dose of 4.0 μg/0.3 μL/site for p‐ERK1/2 ( p = 0.001, Dunn). D‐AP5 pretreatment failed to affect the expression of t‐ERK1/2 (C, p = 0.996, n = 6, ANOVA) and t‐CREB (E, p = 0.798, n = 6, ANOVA) in the NAc. p‐ERK1/2 = phosphorylated ERK1/2, t‐ERK1/2 = total ERK1/2, p‐CREB = phosphorylated CREB, t‐NR2B = total CREB. The normally distributed data were analysed with one‐way ANOVA, and Dunnett's post hoc test was conducted for multiple comparisons; otherwise, the data that did not meet the criteria of normal distribution were analysed by Kruskal–Wallis test with Dunn's post hoc analysis for multiple comparisons. Compared with the vehicle group, ** p < 0.01, *** p < 0.001.

    Journal: Addiction Biology

    Article Title: NMDA receptor within nucleus accumbens shell regulates propofol self‐administration through D1R/ERK/CREB signalling pathway

    doi: 10.1111/adb.13401

    Figure Lengend Snippet: Images and plots of western blotting analysis of D1R/ERK/CREB signalling pathway in the NAc after the pretreatment of D‐AP5 in bilateral NAsh in propofol self‐administrated rats. The expressions of D1R (A, p < 0.001, n = 7, ANOVA), p‐ERK1/2 (B, p = 0.001, n = 7, Kruskal–Wallis) and p‐CREB (D, p = 0.001, n = 7, ANOVA) in the NAc were statistically significantly increased in a dose‐dependent manner by D‐AP5 pretreatment. Compared with the vehicle group, the pairwise analysis showed the difference reached a statistical significance at the dose of 2.0–4.0 μg/0.3 μL/site for D1Rs (2.0 group p < 0.001, 4.0 group p < 0.001, Dunnett) and p‐CREB (p‐CREB, 2.0 group p = 0.003, 4.0 group p = 0.001, Dunnett), and at the dose of 4.0 μg/0.3 μL/site for p‐ERK1/2 ( p = 0.001, Dunn). D‐AP5 pretreatment failed to affect the expression of t‐ERK1/2 (C, p = 0.996, n = 6, ANOVA) and t‐CREB (E, p = 0.798, n = 6, ANOVA) in the NAc. p‐ERK1/2 = phosphorylated ERK1/2, t‐ERK1/2 = total ERK1/2, p‐CREB = phosphorylated CREB, t‐NR2B = total CREB. The normally distributed data were analysed with one‐way ANOVA, and Dunnett's post hoc test was conducted for multiple comparisons; otherwise, the data that did not meet the criteria of normal distribution were analysed by Kruskal–Wallis test with Dunn's post hoc analysis for multiple comparisons. Compared with the vehicle group, ** p < 0.01, *** p < 0.001.

    Article Snippet: The protein was transferred to polyvinylidene fluoride (PVDF) membranes, and the non‐specific binding sites were blocked with 5% skim milk at room temperature for 2 h. After that, the bands were incubated in primary antibody [NR2A, p‐NR2A (Tyr1246), NR2B, p‐NR2B (Tyr1472), p‐ERK and p‐CREB, rabbit, 1:1000, Cell Signaling Technology, Danvers, MA, United States; D1R, ERK and CREB, mouse, 1:1000, Santa Cruz Biotechnology, Texas, United States] at 4°C overnight and in the secondary antibody (goat anti‐rabbit or goat anti‐mouse, 1:3000, Proteintech, Chicago, United States) that diluted with tris‐buffered saline (TBST) at room temperature for 2 h. We adopted glyceraldehyde‐3‐phosphate dehydrogenase (GAPDH) (mouse, 1:10000, Proteintech, Chicago, United States) as the internal control.

    Techniques: Western Blot, Expressing

    Primers used for RT-PCR analysis

    Journal: Translational Neuroscience

    Article Title: Vitamin D3 reduces hippocampal NR2A and anxiety in nicotine withdrawal mice

    doi: 10.1515/tnsci-2020-0166

    Figure Lengend Snippet: Primers used for RT-PCR analysis

    Article Snippet: NR2A primary antibody (19953-1-AP, 1:800) and GAPDH primary antibody (10494-1-AP, 1:10,000) were purchased from proteintech.

    Techniques: Sequencing

    The hippocampal upregulation of NR2A level induced by nicotine withdrawal is corrected in mice fed with the vitamin D3-supplemented diet. NR2A mRNA level (a) and protein level (c) were significantly decreased after receiving vitamin D3 supplement, compared to nicotine-treated mice ( n = 8). There was a slight but significant decrease in hippocampal α7 nAChR in the nicotine-treated and vitamin D3-supplemented mice, compared with the vehicle group ( n = 8), both in mRNA expression (b) and in protein level (d). GAPDH was used as a reference protein ( n = 8). Data were expressed as mean ± SEM. Compared with the vehicle group * P < 0.05, ** P < 0.01; compared with the Nic group, # P < 0.05, ## P < 0.01.

    Journal: Translational Neuroscience

    Article Title: Vitamin D3 reduces hippocampal NR2A and anxiety in nicotine withdrawal mice

    doi: 10.1515/tnsci-2020-0166

    Figure Lengend Snippet: The hippocampal upregulation of NR2A level induced by nicotine withdrawal is corrected in mice fed with the vitamin D3-supplemented diet. NR2A mRNA level (a) and protein level (c) were significantly decreased after receiving vitamin D3 supplement, compared to nicotine-treated mice ( n = 8). There was a slight but significant decrease in hippocampal α7 nAChR in the nicotine-treated and vitamin D3-supplemented mice, compared with the vehicle group ( n = 8), both in mRNA expression (b) and in protein level (d). GAPDH was used as a reference protein ( n = 8). Data were expressed as mean ± SEM. Compared with the vehicle group * P < 0.05, ** P < 0.01; compared with the Nic group, # P < 0.05, ## P < 0.01.

    Article Snippet: NR2A primary antibody (19953-1-AP, 1:800) and GAPDH primary antibody (10494-1-AP, 1:10,000) were purchased from proteintech.

    Techniques: Expressing

    VGlut2 expression in the left and right visual cortex

    Journal: Experimental neurology

    Article Title: Neurosteroid allopregnanolone reduces ipsilateral visual cortex potentiation following unilateral optic nerve injury

    doi: 10.1016/j.expneurol.2018.05.005

    Figure Lengend Snippet: VGlut2 expression in the left and right visual cortex

    Article Snippet: Membranes were blocked in 5% non-fat milk probed with primary antibodies against VGlut2 (1:5000, AB2251, Millipore), GABA A receptor δ-subunit (1:500, AB9752, Millipore), NR2A (1:1000, AB1555P, Millipore).

    Techniques: Expressing